Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

This study has suspended participant recruitment.
(researchers delay)
Sponsor:
Information provided by:
King Faisal University
ClinicalTrials.gov Identifier:
NCT01132417
First received: September 19, 2009
Last updated: June 21, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)